Recipharm has signed an agreement on the EQMS (Electronic Quality Management System) product FormPipe Life Science to streamline multiple quality and compliance processes. The total order value amounts to 2.5 million SEK to FormPipe Software.

Recipharm is a leading contract development and manufacturing organisation (CDMO) employing some 1,700 employees. The scope of this order includes four of the ten subsidiaries in the Recipharm Group and the implementation will be delivered by FormPipe Software’s partner Sigma.

“We believe that implementing FormPipe Life Science will drive efficiency in our operations by simplifying the processes for documentation and case management, which will add value to our customers”, says Staffan Widengren, General Manager of Recipharm Strängnäs.

In the pharmaceutical industry quality control is rigorous and concerns all parts of the organization, from research and development to manufacturing and distribution of drugs. Work within production and quality are being controlled by the pharmaceutical industry's stringent quality standards and Good Manufacturing Practice (GMP). National drug authorities carry out inspections to ensure the compliance with GMP. Dealing with highly regulated processes also puts high demands on the IT support which must live up to these same high GMP requirements.

“This order from Recipharm shows that our investment in the Life Science sector now is beginning to transform into tangible orders. After being present on the Life Science-market for some time this order and the experiences we have gained during this time significantly strengthens our belief that we have a competitive and user friendly offer to these companies”, explains Christian Sundin, CEO of FormPipe Software.  

This is a translation of the original Swedish version. In the event of any discrepancies between the two versions, the original Swedish version shall take precedence.


For additional information, contact:

Christian Sundin, President and CEO of FormPipe Software AB, +46 705 67 73 85

For additional information about FormPipe Life Science: www.formpipe.com/lifescience

 

The information in this press release is of the kind that FormPipe Software AB (publ) is required to disclose in accordance with the Swedish Securities Markets Act and/or the Swedish Financial Instruments Trading Act. This information was submitted for publication on Tuesday, 11 December 2012.